Impact of bacterial pneumonias on world child health

Paediatric Respiratory Reviews

Volumn 1, Issue 1, 2000, Pages 21-25

  English, M ^a,b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Child health; Lower respiratory infection; Pneumonia

Indexed keywords

EID: 10644222697     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1053/prrv.2000.0008     Document Type: Conference Paper

References (16)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.
2. World Bank. World Development Report 1993. Oxford: Oxford University Press, 1993.
3. Scott JA, Hall AJ. Acute respiratory infections: the forgotten pandemic. Communique from the International Conference on Acute Respiratory Infections, held in Canberra, Australia, 7-10 July 1997. Int J Tuberc Lung Dis 1998; 2: 2-4.
4. Scott JA, Hall AJ. The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community acquired pneumonia. Chest 1999; 116: 1716-1732.
5. Mulholland KHS, Adegbola R, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, Lahai G, Jaffar S, Secka O, Lin K, Ethevenaux C, Greenwood B. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349: 1191-1197.
6. Forgie IM, Campbell H, Lloyd-Evans N, Leionen M, O'Neill KP, Saikku P, Whittle HC, Greenwood BM. Etiology of acute lower respiratory tract infections in children in a rural community of The Gambia. Paediat Infect Dis J 1992; 11: 466-473.
7. Black SSH, Ray P, Lewis E, Fireman B. The Kaiser Permanente Vaccine Study Group. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: results of the Northern California Kaiser Permanent Efficacy Trial. Proceedings from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy 1998, San Diego, USA: LB-9.
8. Hausdorf WP, Kloek C, Bryant J. The relative importance of specific pneumococcal serogroups as causes of disease, analysed by geographical setting, age group, disease state and clinical site of isolation. Pneumococcal Vaccines for the World. 1998, Washington D.C.: 12.
9. Victora CG, Kirkwood BR, Ashworth A, Black RE, Rogers S, Sazawal S, Campbell H, Gove S. Potential interventions for the prevention of childhood pneumonia in developing countries: improving nutrition. Am J Clin Nutr. 1999; 70: 309-320.
10. WHO. Acute respiratory infections in children: case management in small hospitals in developing countries. 1990.
11. Sazawal S, Black R. Meta-analysis of intervention trials on case management of pneumonia in community settings. Lancet 1992; 340: 528-533.
12. English MC, Punt J, Mwangi I, McHugh K, Marsh K. Clinical overlap between malaria and severe pneumonia in African children in hospital. Trans Roy Soc Trop Med Hyg. 1996; 90: 658-662.
13. Selwyn BJ on behalf of the co-ordinated data group of Bostid researchers. The epidemiology of acute respiratory infections in young children: comparison of findings from several developing countries. Rev Infect Dis. 1990; 12(Supplement 8): S870-888.
14. Straus WL, Qazi SA, Kundi Z et al. Antimicrobial resistance and the clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: a randomised clinical trial. Lancet 1998; 352: 270-274.
15. Crook DWM, Spratt BG. Multiple antibiotic resistance in Streptococcus pneumoniae. Br Med Bull 1998; 54: 595-610.
16. Butler JC, Dowell SF, Breiman RF. Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention. Vaccine 1998; 16: 1693-1697.